Researchers at Westlake University in Hangzhou, China, have developed a handheld device that detects cancer biomarkers from one drop of blood [2].
This technology could lower the barriers to early cancer diagnosis by replacing expensive, bulky laboratory equipment with a portable tool. Faster and cheaper screening may increase accessibility for patients in remote or underserved regions.
The nanophotonic sensing device is designed to identify specific biomarkers associated with cancer [2]. According to the research team, the device is up to 10,000 times more sensitive and accurate than traditional detection methods [1].
Wen Liaoyong, a researcher at Westlake University, said the project focused on extreme miniaturization. He said the team reduced the system from the size of a refrigerator to a handheld unit [1].
"We have transformed a cancer detection system that once required equipment the size of a refrigerator into something that fits in your hand while improving its accuracy nearly 10,000‑fold," Wen said [1].
The device relies on nanophotonics to analyze a minimal sample volume [2]. By requiring only a single drop of blood, the system minimizes the invasiveness of the testing process while maintaining high precision [2]. This shift toward handheld diagnostics aims to make cancer screening a more routine part of healthcare, rather than a complex hospital procedure.
“The device is up to 10,000 times more sensitive and accurate than traditional detection methods.”
The transition from refrigerator-sized diagnostic machinery to handheld sensors represents a shift toward decentralized medicine. If these sensitivity claims are validated in broader clinical settings, the ability to perform high-accuracy screenings outside of specialized laboratories could lead to significantly higher early-detection rates, which is the primary factor in improving cancer survival outcomes.
